We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$11.3B
AUM Growth
+$1.62B
Cap. Flow
+$896M
Cap. Flow %
7.96%
Top 10 Hldgs %
56.76%
Holding
110
New
30
Increased
24
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$171M
2
TWX
Time Warner Inc
TWX
+$146M
3
NXPI icon
NXP Semiconductors
NXPI
+$145M
4
KITE
Kite Pharma, Inc.
KITE
+$136M
5
TRU icon
TransUnion
TRU
+$106M

Top Sells

Rank Stock Value
1
MBLY
Mobileye N.V.
MBLY
+$371M
2
SBAC icon
SBA Communications
SBAC
+$132M
3
TMH
Team Health Holdings Inc
TMH
+$105M
4
ALR
Alere Inc
ALR
+$82.4M
5
META icon
Meta Platforms (Facebook)
META
+$75.8M

Sector Composition

Rank Sector Weight
1 Technology 23.58%
2 Communication Services 19.94%
3 Healthcare 12.5%
4 Industrials 7.48%
5 Financials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
51
Ionis Pharmaceuticals
IONS
$8.6B
$22.8M 0.2%
+450,000
New +$23.6M
LUMN icon
52
PUT
Lumen
LUMN
$6.57B
$21.6M 0.19%
+1,144,000
New +$24.1M
SVRA icon
53
Savara
SVRA
$1.12B
$20.8M 0.18%
2,225,000
– –
RYAAY icon
54
Ryanair
RYAAY
$30.4B
$20.6M 0.18%
488,455
-108,578
-18% -$4.9M
SNI
55
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$20.2M 0.18%
+235,000
New +$19.3M
SBAC icon
56
SBA Communications
SBAC
$19.2B
$19.7M 0.18%
136,738
-924,231
-87% -$132M
ENTA icon
57
Enanta Pharmaceuticals
ENTA
$366M
$19.3M 0.17%
+412,333
New +$16.6M
MYOK
58
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$17M 0.15%
+397,500
New +$12.7M
SPB icon
59
Spectrum Brands
SPB
$2.04B
$15.6M 0.14%
+147,000
New +$16.5M
HRG
60
DELISTED
HRG Group, Inc.
HRG
$15.4M 0.14%
+985,000
New +$15.9M
SAGE
61
DELISTED
Sage Therapeutics
SAGE
$15.2M 0.13%
243,500
+143,500
+144% +$11.3M
AKBA icon
62
Akebia Therapeutics
AKBA
$354M
$14.4M 0.13%
730,000
– –
RGNX icon
63
Regenxbio
RGNX
$620M
$13.7M 0.12%
+417,000
New +$9.38M
STML
64
DELISTED
Stemline Therapeutics, Inc.
STML
$13.2M 0.12%
1,187,500
+30,000
+3% +$282K
ZEAL
65
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$12.5M 0.11%
+650,000
New +$12.2M
ZGNX
66
DELISTED
Zogenix, Inc.
ZGNX
$11.2M 0.1%
320,000
+145,000
+83% +$1.97M
CLLS
67
Cellectis
CLLS
$277M
$11M 0.1%
+385,000
New +$9.96M
MON
68
DELISTED
Monsanto Co
MON
$10.8M 0.1%
90,000
-125,000
-58% -$14.7M
WGL
69
DELISTED
Wgl Holdings
WGL
$10.1M 0.09%
120,000
– –
CYOU
70
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$9.51M 0.08%
240,000
+79,188
+49% +$3.19M
ANAB icon
71
AnaptysBio
ANAB
$1.58B
$8.6M 0.08%
+246,000
New +$6.64M
NCNA
72
NuCana
NCNA
$5.49M
$7.35M 0.07%
+80
New +$6.9M
MRNS
73
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$6.87M 0.06%
+292,500
New +$3.28M
IOVA icon
74
Iovance Biotherapeutics
IOVA
$1.82B
$6.59M 0.06%
+850,000
New +$5.38M
PCO
75
DELISTED
Pendrell Corporation - Class A
PCO
$5.61M 0.05%
8,211
– –
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Farallon Capital Management held 110 positions worth $11.3B, up 17% from $9.63B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Farallon Capital Management deployed $896M of net new capital in Q3 2017, opening 30 new positions and adding to 24 existing holdings. Its largest new stake was Equifax: 1,290,000 shares worth $137M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was SBA Communications, an estimated $132M trimmed.

  • Farallon Capital Management's largest Q3 2017 buy was Equifax: 1,290,000 shares worth $137M.
  • Farallon Capital Management added most to Time Warner Inc in Q3 2017, an estimated $146M increase.
  • Farallon Capital Management's biggest Q3 2017 reduction was SBA Communications, cutting an estimated $132M.
  • Farallon Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $371M.
  • Farallon Capital Management's ten largest holdings make up 57% of its $11.3B portfolio in Q3 2017.
  • Farallon Capital Management opened 30 new positions and closed 25 in Q3 2017.
  • Farallon Capital Management's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on Farallon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.